A5010111214- Palliative Care and End-of-Life Issues
- Family and Patient Care in Intensive Care Units
- Cancer, Lipids, and Metabolism
- Patient Dignity and Privacy
- COVID-19 Clinical Research Studies
- Psoriasis: Treatment and Pathogenesis
- Bariatric Surgery and Outcomes
- Gastric Cancer Management and Outcomes
- Childhood Cancer Survivors' Quality of Life
- Spondyloarthritis Studies and Treatments
- Patient Satisfaction in Healthcare
- Gestational Diabetes Research and Management
- COVID-19 and healthcare impacts
- Lipid metabolism and disorders
- Systemic Lupus Erythematosus Research
- Liver Disease Diagnosis and Treatment
- Patient-Provider Communication in Healthcare
- Emergency and Acute Care Studies
- Diabetes Management and Education
- Nanoparticle-Based Drug Delivery
- Long-Term Effects of COVID-19
Princess Nourah bint Abdulrahman University
2019-2025
The University of Queensland
2019
This study was performed to identify predictive markers of worse outcomes in patients with severe COVID-19 an intensive care unit.
Background: Obesity is a pathological condition and major risk factor for dyslipidemia, type 2 diabetes, non-alcoholic fatty liver disease. Recent research highlighted the association of non-invasive serum markers with these conditions but clinical utility ALT APRI in obesity its relationship dyslipidemia remain unexplored. Methods: We examined 165 non-diabetic adults stratified by BMI lipid parameters. Results: Obese subjects had significantly higher than lean subjects, an area under curve...